Speakers
Exciting progress is underway regarding surgical options for the breast and axilla in neoadjuvant chemotherapy patients, lymphedema prevention. How COVID-19 has impacted screening delays and the
effects of the vaccine on treatment. The evolution of the role of genomic profiling and genetic testing. Physicians involved with the diagnosis and management of breast cancer patients need to be kept apprised of new information in all of these areas.
Breast Surgeon Oncologist
Symposium Director
Henry Ford Health
Surgical Breast Oncologist
Symposium Co- Director
Registered Dietitian
Henry Ford Health
Manager, HFCI
Clinical Navigation
Henry Ford Health
Radiation Oncologist
Henry Ford Cancer Institute
Medical Oncologist
Henry Ford Cancer Institute
Medical Oncologist
Henry Ford Cancer Institute
Diagnostic Radiologist
Henry Ford Cancer Institute
OB/GYN Oncologist
Henry Ford Health
Henry Ford Health
Henry Ford Health
Surgical Breast Oncologist
Henry Ford Health
Hospitalist
Henry Ford Health
